(IGXT)Mcap 32 M//2x Partnerships THIS Q/1x Approved drug

THIS UNKNOWN GEM IS THE CHEAPEST STOCK WITH THE HIGHEST UPSIDE POTENTIAL IN THE COMPLETE BIOTECH SECTOR .DO YOUR OWN DD AND REALIZE THE MEGA MONSTER POTENTIAL ! GLTA


This Goldmine has a VERY LOW burn-rate of only $1.2 M a year means we have enuff cash untill 2014 EXCLUDING cpi-300 revenue and EXCLUDING upfront payments from upcoming partnerships BUT MORE IMPORTANT TO KNOW IS THAT WE WILL REACH PROFITABILITY THIS YEAR !!!

2x NDA filings for Migraine and Antipsychotic drugs this year which have much bigger market potential than current approved drug .

IGXT has NO DEBT and the Market cap of only 32 M is more than RIDICULOUS for this GOLDMINE .

Intelgenx (IGXT.OB)

Market Cap : $ 32 M
Cash: $ 3.3 M
Price : 0.67 $
NO DEBT

Shares Out : 45 M ( 23 M shares are held by Insiders + Institutions)


HEAVY BUYING BY INSTITUTIONS
http://data.cnbc.com/quotes/IGXT.OB/tab/8


Burn-rate only 300K per Q / IGXT has 3.3 M cash / Do the Math !
http://images.investorshub.advfn.com/images/uploads/2012/1/11/yimmb...



PARTNERDEAL THIS Q
http://images.investorshub.advfn.com/images/uploads/2012/1/11/wliyl...


Sales Potential for approved drug CPI-300
http://images.investorshub.advfn.com/images/uploads/2012/1/11/tzofm...


Profitability and 2 new NDA filings in 2012
http://images.investorshub.advfn.com/images/uploads/2012/1/11/bnavd...


MONSTER PIPELINE including a Blockbuster
http://images.investorshub.advfn.com/images/uploads/2012/1/11/hksav...


Biomedreport Article from Nov 2011
http://www.biomedreports.com/2011111183312/fda-spproval-is-a-game-c...